Thalidomide-NH-C6-NH2 (TFA), 500mg

Methyl 3-(4-(aminomethyl)phenyl)propanoate hydrochloride, 95.0%, 250mg

1-ethyl-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine-3-carboxylic acid hydrochloride hydrate, 95.0%, 250mg

(S)-(+)-1-Chloro-2-methylbutane>98.0%(GC)25mL

5-Hydroxy-1H-pyridin-2-one, 95.0%, 100g

5-(Aminomethyl)-2-chlorobenzonitrile, 97%, 100mg

tert-butyl 3'-amino-4',5'-dihydro-2'H-spiro[cyclopentane-1,6'-pyrrolo[3,4-c]pyrazole]-5'-carboxylate, 98%, 5g

2,6-Dichloro-4-(hydroxymethyl)phenol, 97%, 100mg

5-Bromo-2-chloro-3-iodopyridine, 95.0%, 250mg

1-Methylimidazo[1,5-a]pyridine-3-carboxylic acid, 98%, 1g

2-(4-Bromo-phenyl)-ethanol, 97.0%, 100g

(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(3-(trifluoromethyl)phenyl)propanoic acid, 98%, 5g

2-((TERT-BUTOXYCARBONYL)AMINO)-2-(4,4-DIFLUOROCYCLOHEXYL)ACETIC ACID, 95.0%, 500mg